Walking a tightrope: targeting neutrophils to treat chronic obstructive pulmonary disease
- PMID: 25932758
- DOI: 10.1164/rccm.201502-0361ED
Walking a tightrope: targeting neutrophils to treat chronic obstructive pulmonary disease
Comment on
-
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med. 2015 May 1;191(9):1001-11. doi: 10.1164/rccm.201405-0992OC. Am J Respir Crit Care Med. 2015. PMID: 25695403 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical